Opening the book…
After completing this chapter, you should be able to:
- Describe the purposes of instructions, data records, and quality commitments.
- Explain the roles of laboratory notebooks, SOPs, forms, logs, labels, training records, master batch records, and completed batch records.
- Apply good documentation practices to paper and electronic records.
- Distinguish a performer’s signature, independent verification, record review, and release authorization.
- Explain how change control, retention, and retrieval protect records throughout their life cycle.
Imagine that a laboratory result looks unusual, but the analyst who ran the test is away. Can someone else find the method, check the calculations, and understand what happened? Good documentation makes that possible. This chapter explains how instructions and records help biotechnology teams work consistently, investigate problems, and make decisions they can support with evidence.
- 13.1: The Importance of Documentation
- This page emphasizes the critical role of documentation in understanding processes and outcomes across various fields, especially production. It highlights the importance of traceability through detailed records for assessing complaints and failures, while outlining regulatory requirements, particularly in pharmaceuticals and medical devices.
- 13.2: Types of Documentation
- This page categorizes organizational documents into three types: directive documents (procedures), data collection records (events and activities), and commitment documents (policies and responsibilities). Each type serves distinct purposes, though there may be some overlap in their functions.
- 13.3: Good Documentation Practices
- This page discusses Good Documentation Practice (GDocP) as a means to ensure trustworthy records, emphasized by FDA guidance. It highlights the ALCOA principles (Attributable, Legible, Contemporaneous, Original, Accurate) and the expanded ALCOA plus for effective record-keeping.
- 13.4: Signatures and Independent Verification
- This page highlights the significance of signatures and initials in identifying individuals in regulatory contexts, especially in pharmaceuticals. It stresses independent verification by qualified personnel and outlines when a supervisor's signature is necessary. The page also discusses standards for electronic signatures, emphasizing their uniqueness and traceability to promote accountability in compliance with organizational and regulatory guidelines.
- 13.5: Laboratory Notebooks
- This page discusses the importance of laboratory notebooks as essential records in research. They document plans, methods, observations, and interpretations, ensuring clarity for reproducibility. Both physical and electronic formats are valid, provided they maintain attribution and traceability. Key elements include raw data, metadata, and effective retention practices to preserve integrity and protect intellectual property, while differentiating honest errors from falsifications.
- 13.6: Standard Operating Procedures
- This page discusses Standard Operating Procedures (SOPs), emphasizing their role in standardizing recurring tasks, aiding training, and ensuring safety. It highlights the importance of clear instructions, involvement from knowledgeable personnel, and formal approval by technical staff. SOPs must include essential components such as title, identifier, revision date, responsibilities, and detailed instructions.
- 13.7: Forms, Protocols & Reports
- This page discusses the importance of forms in accurately recording information like lot numbers and observations. It emphasizes the need for clear presentation to avoid premature entries and stresses that records must reflect actual work completed. Reviews must ensure the accuracy and consistency of records, with signatures clarifying their purpose.
- 13.8: Reports
- This page provides an overview of scientific reports, detailing their structure and essential components, including sections like title, abstract, and methods. It emphasizes clarity, traceability, and the importance of honest communication of findings without biasing towards a hypothesis. The page also highlights the need to consider the audience and adhere to specific guidelines in the Biotechnology Program.
- 13.9: Equipment and Instrument Logbooks
- This page emphasizes the importance of equipment logs for tracking usage, maintenance, and repairs, whether in paper or electronic form. It highlights the necessity for unique identification of equipment and detailed records, including status and personnel.
- 13.10: Instrument and Computer Records
- This page emphasizes the importance of maintaining comprehensive instrument records, covering various data types and identification details. It stresses secure storage and attachment of outputs, preservation of record relationships, and effective management of monitoring systems. Additionally, it highlights the necessity of strict controls in computer systems to ensure compliance and maintain data integrity in regulated environments.
- 13.11: Analytical Laboratory Documentation
- This page discusses the importance of analytical records in laboratories, covering environmental, clinical, and pharmaceutical contexts. Key components include method information, sample details, and performance data. It emphasizes the distinction between detection and acceptance limits, and highlights regulatory requirements for pharmaceutical testing, such as those outlined in 21 CFR 211.194, ensuring results are substantiated by sufficient evidence.
- 13.12: Identification Systems and Labels
- This page covers identification systems for materials and products, particularly lot numbers, which can be numeric or alphanumeric. It underscores the need for traceability through links between internal identifiers and supplier lot numbers. The page also focuses on the importance of labels for conveying essential information, including safety and usage guidelines, and specifies required label content for laboratory solutions.
- 13.13: Chain of Custody
- This page emphasizes the significance of chain of custody documents for maintaining accountability in sample handling and possession, crucial for legal evidence and environmental testing. It outlines the necessity of unique sample identifiers and thorough transfer records, detailing who handled the samples, under what conditions, and when. The absence of accurate records can jeopardize the reliability of test results. An adaptable example of a chain-of-custody form is included.
- 13.14: Training Records
- This page emphasizes the critical importance of education, training, and experience for personnel in pharmaceutical operations, as mandated by 21 CFR 211.25. Continuous training on cGMP is required, with thorough documentation of training records. Managers and qualified trainers are responsible for overseeing training, which must remain relevant and updated. While additional skills may aid professional growth, they do not ensure increased compensation.
- 13.15: Master and Completed Batch Records
- This page outlines 21 CFR regulations concerning master production and batch records for pharmaceuticals. It defines the master batch record (MBR) as a standardized document that ensures consistency, while the batch production record (BPR) records actual production details, requiring accuracy and approvals. The page highlights the necessity of controlled records, including deviations and lab results, and states that drug batch records should be retained for one year after expiration.
- 13.16: Regulatory Submissions and Product Release
- This page outlines the process of regulatory submissions for drug investigations, emphasizing that an IND does not ensure marketing approval. It describes the role of a quality unit in assessing production and control prior to batch release, adherence to compliance, and the importance of defined staff roles.
- 13.17: Electronic Documentation
- This page discusses the record-keeping systems used by biotechnology organizations, highlighting the importance of compliance with 21 CFR Part 11 for electronic records. It emphasizes essential practices such as software validation, access controls, and retention of metadata. Key concepts include electronic signatures, encrypted records, and the distinction between closed and open systems, all aimed at ensuring information preservation and accurate retrieval.
- 13.18: Managing Changes in Documentation
- This page discusses the importance of controlled procedures and change control for maintaining quality and compliance. It highlights the need to assess the impact of changes on safety and regulatory factors before implementation. Authorized personnel can initiate change requests, which are then managed by document-control staff who release updates and maintain records.
- 13.19: Storage Retention and Retrieval
- This page underscores the necessity of safeguarding records against loss, damage, and unauthorized access through proper measures like access controls and backups. It advises against universal retention timelines, emphasizing the need for retention periods aligned with legal requirements.
- 13.20: Documentation Requirements and Oversight
- This page outlines regulatory compliance for pharmaceuticals, detailing 21 CFR Part 211 sections on quality assurance and documentation. It highlights verification needs for various products, including GLP and clinical research. The page explains the FDA's Form 483 and warning letters related to inspections.
- 13.21: Chapter Summary
- This page emphasizes the critical role of quality documentation in biotechnology, focusing on the ALCOA principles for reliable records and the significance of clear document control. It details specific forms for Standard Operating Procedures (SOPs) and their documentation, including training records and packaging work orders.
This page titled 13: Quality Documentation was last modified on Sat, 31 Oct 2026 15:05:36 GMT and is shared under a CC BY-SA 4.0 license and was authored, remixed, and/or curated by .
The book could not be loaded just now.